CPT 0330U: Bridge Women’s Health 27-Pathogen Vaginal NAAT
Headline: New PLA CPT code 0330U identifies a 27-pathogen NAAT for vaginal infections
Lead: CPT code 0330U designates the Bridge Women’s Health Infectious Disease Detection Test, a proprietary nucleic acid amplification test (NAAT) for detecting 27 vaginal pathogens from a vaginal swab. The code enables clear reporting for a single manufacturer’s assay and supports national tracking of molecular testing for common vaginal infections.
Why it matters: As molecular diagnostics expand, PLA codes like 0330U provide specificity for payer adjudication, utilization monitoring, and clinical decision support. Accurate reporting affects coverage determination, claims processing, and surveillance of common reproductive tract infections.
Payers covered: This analysis addresses major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication explains the clinical scope of CPT code 0330U, typical service context (laboratory NAAT on vaginal swab specimens), and the significance of PLA designation. It summarizes expected topics readers can use: code definition and clinical context, payer coverage considerations, common modifiers used in lab billing, and implications for billing workflows and test reporting. Where input lacks details, the publication notes missing specifics as “Data not available in the input.”
Customize your policy alerts
Sign up for cpt 0330U policy alerts
Get alerted when payer policies referencing 0330U are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 0330U is a Proprietary Laboratory Analyses (PLA) code for the Bridge Women’s Health Infectious Disease Detection Test produced by Bridge Diagnostics. This nucleic acid amplification test (NAAT) evaluates a vaginal swab specimen for the presence or absence of 27 vaginal pathogens, including bacteria such as Gardnerella vaginalis, various Candida species (yeast), and Trichomonas vaginalis (TV).
Service type: Laboratory testing — molecular diagnostic NAAT
Typical site of service: Clinical laboratory or outpatient collection site where vaginal swab specimens are collected and submitted to the performing laboratory for analysis.